Some scientists surprised Oval Office used to release preliminary antiviral drug details

The top U.S. infectious disease official says concerns over leaks compelled him to reveal data on Gilead Sciences Inc.'s experimental drug remdesivir, the first in a scientifically rigorous clinical trial to show benefit in treating COVID-19.

from CBC | Health News https://ift.tt/2zNvWU5